Doctor profile · Federal record
Dr. Sharron Blaylock, M.D.
Internal Medicine Physician (CMS: Dermatology) · Bartlesville, OK
- NPI 1588628978
- Accepts Medicare
- MIPS 100.0 / 100 · 2023
- 30 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
309 Se Frank Phillips Blvd
Bartlesville, OK 740033643
(918) 214-8888
fax (918) 214-8887
Credentials & registration
- NPI registered
- April 2006 — 20 yrs on file
- Profile last updated
- January 9, 2023
- Year of graduation
- 1996 — 30 yrs since
- Specialty taxonomy
- 207R00000X — NUCC code
- State license (1)
- Oklahoma #24824
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1588628978. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
2,466
Distinct HCPCS
10
Medicare allowed
$118,180
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 1,009 | 198 | $6 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 632 | 494 | $81 | |
17000 |
Destruction of precancer skin growth, 1 growth | 343 | 266 | $53 | |
11102 |
Biopsy of related skin growth, first growth | 146 | 140 | $88 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 104 | 104 | $100 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 69 | 66 | $51 | |
17110 |
Destruction of skin growth, 1-14 growths | 46 | 46 | $100 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 33 | 32 | $116 | |
11103 |
Biopsy of related skin growth, each additional growth | 25 | 23 | $43 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 18 | 16 | $151 |
In context: peer comparison
Among 3 peers in Bartlesville Internal Medicine Physician, average services per provider: 177. This provider delivers 14× the peer median.Open Payments
Industry payments received
All-time total
$859
Transactions
46
Manufacturers
12
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 18 | $291.15 | |
| E.R. Squibb & Sons, L.L.C. | 9 | $168.31 | |
| Novartis Pharmaceuticals Corporation | 3 | $87.99 | |
| Sun Pharmaceutical Industries INC. | 4 | $87.54 | |
| Pfizer INC. | 3 | $53.08 | |
| Janssen Biotech, INC. | 2 | $40.52 | |
| Lilly USA, LLC | 2 | $34.48 | |
| Amgen INC. | 1 | $25.11 | |
| Organogenesis INC. | 1 | $21.22 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | 1 | $18.31 | |
| Dermavant Sciences, INC. | 1 | $15.72 | |
| Galderma Laboratories, L.P. | 1 | $15.19 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
218
Patients
121
Total drug cost
$76,684
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ketoconazole | Generic | 53 | 31 | $1,629 |
| Triamcinolone Acetonide | Generic | 38 | 32 | $415 |
| Doxycycline Hyclate | Generic | 28 | 11 | $958 |
| Fluorouracil | Generic | 23 | 21 | $1,929 |
| Dupixent Syringe (Dupilumab) | Brand | 18 | 0 | $68,681 |
| Clobetasol Propionate | Generic | 16 | 13 | $2,265 |
| Pentoxifylline | Generic | 16 | 0 | $620 |
| Hydrocortisone | Generic | 15 | 13 | $138 |
| Prednisone | Generic | 11 | 0 | $48 |
Frequently asked questions
What is Dr. Sharron Blaylock's medical specialty?
Dr. Sharron Blaylock practices Internal Medicine Physician in Bartlesville, OK.
Where does Dr. Sharron Blaylock practice?
Dr. Sharron Blaylock practices at 309 Se Frank Phillips Blvd, Bartlesville, OK 740033643. Office phone: 9182148888.
What is Dr. Sharron Blaylock's NPI?
Dr. Sharron Blaylock's National Provider Identifier (NPI) is 1588628978, issued by NPPES.
Does Dr. Sharron Blaylock accept Medicare assignment?
Yes. Dr. Sharron Blaylock accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Sharron Blaylock commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.